PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature.
PET
PSMA
choline
prognosis
prostate cancer
response to therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
31 Mar 2022
31 Mar 2022
Historique:
received:
18
02
2022
revised:
21
03
2022
accepted:
22
03
2022
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
13
4
2022
Statut:
epublish
Résumé
The aims of this systematic review were to (1) assess the utility of PSMA-PET and choline-PET in the assessment of response to systemic and local therapy, and to (2) determine the value of both tracers for the prediction of response to therapy and survival outcomes in prostate cancer. We performed a systematic literature search in PubMed/Scopus/Google Scholar/Cochrane/EMBASE databases (between January 2010 and October 2021) accordingly. The quality of the included studies was evaluated following the "Quality Assessment of Prognostic Accuracy Studies" tool (QUAPAS-2). We selected 40 articles: 23 articles discussed the use of PET imaging with [
Identifiants
pubmed: 35406542
pii: cancers14071770
doi: 10.3390/cancers14071770
pmc: PMC8997431
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):84-91
pubmed: 26323576
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2105-2113
pubmed: 27317482
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):602-612
pubmed: 29185010
Anticancer Res. 2017 Mar;37(3):1273-1279
pubmed: 28314292
AJR Am J Roentgenol. 2012 Aug;199(2):252-62
pubmed: 22826385
Oncotarget. 2014 Dec 15;5(23):12448-58
pubmed: 25504434
BMC Cancer. 2020 Apr 29;20(1):362
pubmed: 32349700
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):185-191
pubmed: 31620808
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):143-151
pubmed: 32405735
Strahlenther Onkol. 2018 Apr;194(4):318-324
pubmed: 29181556
Oncotarget. 2016 Sep 27;7(39):63747-63757
pubmed: 27572317
J Nucl Med. 2017 Mar;58(3):438-444
pubmed: 27660148
Radiat Oncol. 2018 Mar 2;13(1):37
pubmed: 29499730
Biomedicines. 2020 Nov 30;8(12):
pubmed: 33266047
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Clin Nucl Med. 2021 Jun 1;46(6):465-470
pubmed: 33661210
Clin Transl Oncol. 2019 Mar;21(3):289-297
pubmed: 30006674
J Nucl Med. 2020 Jun;61(6):866-872
pubmed: 31676727
BJU Int. 2020 Oct;126(4):433-435
pubmed: 32579772
Clin Genitourin Cancer. 2017 Oct;15(5):e773-e782
pubmed: 28462855
Clin Genitourin Cancer. 2014 Oct;12(5):312-6
pubmed: 24806400
Cancers (Basel). 2021 Mar 25;13(7):
pubmed: 33805971
Contrast Media Mol Imaging. 2019 Mar 26;2019:4325946
pubmed: 31049043
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1276-83
pubmed: 25808631
Curr Radiopharm. 2017 Nov 10;10(3):195-202
pubmed: 28933270
Future Oncol. 2016 Feb;12(3):333-42
pubmed: 26768648
Clin Transl Oncol. 2018 Apr;20(4):484-490
pubmed: 28795303
J Urol. 2021 Apr;205(4):1082-1089
pubmed: 33207140
World J Urol. 2019 Aug;37(8):1535-1542
pubmed: 30824985
Urology. 2010 Nov;76(5):1072-6
pubmed: 20846711
BJU Int. 2017 Mar;119(3):406-413
pubmed: 27104782
Ann Nucl Med. 2021 Jun;35(6):680-690
pubmed: 33783752
Strahlenther Onkol. 2020 Nov;196(11):1006-1017
pubmed: 32399639
J Nucl Med. 2021 Oct;62(10):1430-1437
pubmed: 33608426
Strahlenther Onkol. 2018 Jul;194(7):638-645
pubmed: 29511777
Cureus. 2020 Nov 28;12(11):e11751
pubmed: 33403181
Strahlenther Onkol. 2020 Nov;196(11):1034-1043
pubmed: 32617620
Clin Genitourin Cancer. 2015 Feb;13(1):39-43
pubmed: 24999168
J Nucl Med. 2015 Dec;56(12):1836-42
pubmed: 26405166
Eur Urol. 2015 Jun;67(6):1160-1167
pubmed: 25301759
Radiother Oncol. 2019 Dec;141:188-191
pubmed: 31668514
Ann Nucl Med. 2019 Dec;33(12):945-954
pubmed: 31587172
Eur Urol. 2014 Feb;65(2):270-273
pubmed: 24295792
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1172-1178
pubmed: 32659332
PLoS One. 2020 Oct 21;15(10):e0240892
pubmed: 33085712
Cancer Invest. 2017 Oct 21;35(9):586-593
pubmed: 28980836
J Nucl Med. 2017 Dec;58(12):1972-1976
pubmed: 28747524
Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):78-83
pubmed: 28540419